Harmony Biosciences Holdings, Inc.
HRMY
$27.85
-$0.52-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 868.45M | 825.94M | 772.53M | 744.85M | 714.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 868.45M | 825.94M | 772.53M | 744.85M | 714.73M |
| Cost of Revenue | 198.34M | 184.21M | 167.33M | 161.33M | 156.82M |
| Gross Profit | 670.11M | 641.74M | 605.19M | 583.53M | 557.92M |
| SG&A Expenses | 272.05M | 241.77M | 238.58M | 230.31M | 221.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 659.98M | 600.31M | 550.67M | 549.81M | 523.91M |
| Operating Income | 208.47M | 225.64M | 221.86M | 195.04M | 190.83M |
| Income Before Tax | 215.06M | 230.46M | 225.14M | 197.20M | 191.80M |
| Income Tax Expenses | 56.38M | 44.78M | 44.24M | 44.48M | 46.31M |
| Earnings from Continuing Operations | 158.69 | 185.68 | 180.90 | 152.72 | 145.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 158.69M | 185.68M | 180.90M | 152.72M | 145.49M |
| EBIT | 208.47M | 225.64M | 221.86M | 195.04M | 190.83M |
| EBITDA | 233.80M | 249.51M | 245.73M | 218.99M | 214.94M |
| EPS Basic | 2.76 | 3.24 | 3.16 | 2.68 | 2.56 |
| Normalized Basic EPS | 2.34 | 2.51 | 2.46 | 2.16 | 2.11 |
| EPS Diluted | 2.71 | 3.18 | 3.10 | 2.62 | 2.51 |
| Normalized Diluted EPS | 2.29 | 2.46 | 2.41 | 2.12 | 2.07 |
| Average Basic Shares Outstanding | 229.97M | 229.43M | 228.75M | 228.08M | 227.54M |
| Average Diluted Shares Outstanding | 234.37M | 233.89M | 233.27M | 232.39M | 231.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |